StockNews.AISignal intelligence
Company intelligence

AVBP

ArriVent BioPharma, Inc. Common Stock · NASDAQ · Healthcare

Price$31.35+10.93% · +$3.09
Market cap1.46BEquity value
P / E-9.0Trailing ratio
Volume961.65KLatest session
Market data

AVBP price chart

TradingView
Related signals
1 min delayed

Browse public AVBP signals with their source context and measured market impact. Open any signal for its permanent analysis page.

AVBPJul 2, 2025-0.57% since signal

Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures rose, with Dow futures up 0.2%. Centene withdrew 2025 guidance, causing a 27.7% drop in shares. ArriVent BioPharma fell 5.4% after announcing a $75 million stock offering. Molina Healthcare and BrightView Holdings also reported significant pre-market declines. Overall market trends show a cautious outlook amidst earnings guidance withdrawals.

View signal analysis
Research

Company intelligence